Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period. [electronic resource]
Producer: 20060209Description: 136-45 p. digitalISSN:- 1369-7137
- Alkaline Phosphatase -- analysis
- Biomarkers
- Bone Density
- Bone Remodeling -- drug effects
- Bone and Bones -- drug effects
- Collagen -- urine
- Collagen Type I
- Double-Blind Method
- Estradiol -- pharmacology
- Estrogen Replacement Therapy -- methods
- Female
- Humans
- Megestrol -- pharmacology
- Menopause -- drug effects
- Middle Aged
- Norpregnadienes -- pharmacology
- Osteocalcin -- analysis
- Peptides -- urine
- Progesterone Congeners -- pharmacology
- Quality of Life
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.